Search Results
28 items found for ""
- Richard Liu | Hememics
< Back Go back A Bit About Richard Liu CFO Extensive professional experiences in capital markets, financial analysis, accounting and auditing ​MBA from Johnson Graduate School of Management, Cornell University; BBA from Baruch College, City University of New York. He is a CFA Charterholder and was a CPA in New York State.​ Successfully oversaw equity trading desk with hundreds of millions of shares of trading volume in the US, EU, and Japan and brought direct positive impact to P&L by leveraging technology to improve execution speed and quality with lower commissions. < Previous Next >
- News | Hememics
Latest News July 20th, 2023 Global Startup Heat Map. Discover 5 Top Point-of-Care (POC) Diagnostics Startups Read More June 8th, 2023 Hememics Biotechnologies, Inc. and General Graphene Corporation Cement Strategic Partnership for Large-Scale Production of Graphene-Based Biosensors Read More June 7th, 2023 TEDCO Invests SSBCI Funding into Hememics Biotechnologies, Inc. Read More June 8th, 2023 Partnership to Mass-Produce Graphene Biosensors Read More June 1st, 2023 Hememics to Showcase Rapid Point of Care Biosensor System at 2023 AACC Expo in Anaheim, CA Read More May 25th, 2023 Hememics Biotechnologies Closes $2M Seed 2 Round Read More July, 2020 U. S. Cities Pilot Connected-Vehicle Tech: Enabling Conventional Vehicles to Communicate Could Save Lives Right Now Read More May 25th, 2023 Hememics Biotechnologies, Inc. Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth Read More April 21, 2020 Company: New Coronavirus Test Could Diagnose The Virus in 60 Seconds or Less Read More July, 2020 Biosensors for On-The-Spot Tests: Two Companies Plan to Debut New Tech for COVID-19 Testing by Year's End Read More May 30th, 2023 Handheld Multiplexed Biosensor Platform Tests Antibodies, Antigens and Molecular Targets Simultaneously Read More VIEW ALL
- John L. Warden, Jr. | Hememics
< Back Go back A Bit About John L. Warden, Jr. Co-Founder & CEO Entrepreneurial and executive roles in 5 start-up companies to date, returning more than $75M in net profits to investors. Successful business development experience with Biovista, a drug development services provider to major pharmaceutical companies. Significant impact building markets for technology products. Developed, engineered and constructed the proprietary software and hardware for the HemChip®, HemBox®, and HemStation®. < Previous Next >
- Privacy Policy | Hememics
Privacy Policy Welcome to the Privacy Policy of Hememics ("we" or "us"). This Policy applies to all information collected by Hememics during your use of this website ("site"). We kindly request that you carefully read this information before accessing any part of the site. ​ Our Commitment to Your Privacy ​ At Hememics, we acknowledge and respect the privacy of our site users. In order to better protect your privacy, we have developed this Policy to explain our online information practices and how we collect and utilize information obtained from you. Please note that Hememics may update this Policy periodically without prior notice. You can access the most recent version of this Policy through the "Terms & Conditions of Use" link located at the bottom of every page on this site. General ​ Hememics may collect information about visitors to this site by tracking the usage of certain features available here. This information helps us tailor the content of the site to suit your needs and keep you informed about topics of interest. ​ Specifically, when you provide personally-identifiable information on this site, Hememics may collect it responsibly. This may include details such as your name, mailing address, telephone and/or facsimile number, email address, and other similar information. Hememics will handle your personally-identifiable information in a secure manner, utilizing both online and offline measures. This collection of personally-identifiable information enables Hememics to provide individuals with relevant information about Hememics products and services. We might share this information with our vendors and partners to tailors our offering to your needs. ​ Furthermore, Hememics may store and disclose personally-identifiable information as permitted or required by applicable law. We may make necessary disclosures to protect the rights, safety, or property of Hememics or others, comply with legal or regulatory requirements, or investigate and prevent violations of our Terms and Conditions. Except as mentioned above, Hememics will not disclose, sell, lease, or rent your personally-identifiable information. ​ Use of Cookies and Other Web Technologies ​ Cookies are small data text files that may be stored on your computer's hard drive if your web browser allows it. Most web browsers provide instructions on how to prevent the acceptance of new cookies, receive notifications when you receive a new cookie, or disable most cookies altogether. Even if you reject the use of cookies, you can still use this site. However, please note that by refusing to accept cookies, you may not be able to access certain tools and features offered on our site. ​ Cookies may be used by some of the websites we link to. Therefore, we encourage you to review the Links section of this Policy below. Additionally, we may use your Internet Protocol (IP) address to analyze trends, administer this site, and gather general demographic information in order to improve its functionality. On this site, we may use cookies to enhance navigation and perform the following functions: ​ Recognize your web browser as a returning visitor and remember any preferences set during your previous visits. Customize the content provided to you based on your apparent interests, as your web browser navigates the internet. Measure and research the effectiveness of our site's features, offerings, and email communications by determining which emails you open and engage with. ​ While we may use cookies to improve your navigation experience on this site, please be aware that some of the external websites we link to might also employ cookies. Therefore, we advise you to review the Links section of this Policy below. Additionally, we may use your Internet Protocol (IP) address to analyze trends, administer this site, and gather general demographic information to enhance its overall performance. We will not link any collected IP addresses to personally-identifiable information. ​ Automatic Information ​ As described above, we may automatically collect some information about your computer when you visit our sites. This data might include session data, including your IP address, web browser software, and referring site. We also may collect information about your online activity, such as content viewed and pages visited. We collect this automatic information to help us understand the interests of our customers and visitors and customize your user experience, among other things. ​ Our Commitment to Children's Privacy ​ Protecting the privacy of the very young is especially important. For that reason, Hememics does not intend to or knowingly collect or maintain personally-identifiable information from children under 13. Correcting or Retrieving Your Information ​ If your personally-identifiable information changes or if you no longer want Hememics to maintain your information, you can accomplish this by sending us an email at infomation@hememics.com or by sending your request to: ​ Hememics Biotechnologies, Inc 401 Professional Drive, Suite 220 Gaithersburg, MD 20879-3445 ​ Hememics will send a confirming email to your last known email address regarding the changes or deletion of your personally-identifiable information. ​ Contact Us ​ If you have any questions about this Policy or our site, please contact us at infomation@hememics.com .
- Hem Station | Hememics
Hem Station Bring Lab Test to The Next Level ® HemStation Back The HemStation ® biosensor system is a compact laboratory device able to rapidly and accurately test bio-hazards present in water, soil, and infected persons. ​ The HemStati on ® used with the Hem Chip ® are able to simultaneously identify multiple biothreats and yield sensitive, selective, and measurable data in real-time. ​ This data can be stored on the device and transmitted once a Bluetooth device with a secure user account is within range. < Previous
- Patents & Documents | Hememics
Patents & Documents
- All News 1 | Hememics
All News July 20th, 2023 Global Startup Heat Map: Discover 5 Top Point-of-Care (POC) Diagnostics Solutions Startups Read more June 8th, 2023 Hememics Biotechnologies, Inc. and General Graphene Corporation Cement Strategic Partnership for Large-Scale Production of Graphene-Based Biosensors Read more June 8th, 2023 Partnership to Mass-Produce Graphene Biosensors Read more June 7th, 2023 TEDCO Invests SSBCI Funding into Hememics Biotechnologies, Inc. Read more June 1st. 2023 Hememics to Showcase Rapid Point of Care Biosensor System at 2023 AACC Expo in Anaheim, CA Read more May 30th, 2023 Handheld Multiplexed Biosensor Platform Tests Antibodies, Antigens and Molecular Targets Simultaneously Read more May 26th, 2023 Gaithersburg diagnostic company Hememics Biotechnologies nabs millions ahead of larger funding round Read more May 25th. 2023 Hememics Biotechnologies Closes $2M Seed 2 Round Read more Next >
- FAQ | Hememics
FAQ Q: What is a Bios ensor ? Q: What is Multiplexing ? Q: What are Customized Assays ? Q: What makes Hememics unique?
- Contact Us | Hememics
Get in Touch Feel free to reach out to Hememics First Name Email Last Name Phone Number Subject Message By submitting this form, I acknowledge the receipt of the Hememics Privacy Policy Fields marked with an asterisk ( * ) are required. FAQ Send
- Publications | Hememics
Hememics Related Publications
- HemChip | Hememics
He m Chi p Panel Development for Point of Care ® HemChip ® Back The Hem Chip ® is a small, portable, and disposable biosensor configured for multiplexing. ​ The Hem Chip ® is made with a bior eceptor layer and a proprietary biochip, designed to detect pathogens with utmos t speed, accuracy, and sensitivity. ​ Each Hem Chip ® contains multiple biosensors, enabling the detection of multiple pathogens simultaneously. The Hem Box ® and Hem Chip ® work in tandem, with the Hem Box ® interpreting the signals that the Hem Chip ® outputs, giving the user their real-time results in less than 5 minutes. ® ® Next >
- HemBox | Hememics
Hem Box Impressively Fast & Precise ® HemBox Back < Previous The Hem Box ® biosensor system is a handheld, field hardened, e nviron mentally resilient analytical device made for rapid on-site identification of bio-hazards present in water, soil, and infected persons. ​ ​ The Hem Box ® can simultaneously identify multiple biological threats and yield sensitive, selective, and measurable data in real time. ​ This data can be stored on the device and transmitted once a Bluetooth device with a secure user account is within range. Next >